How to Treat Obstructions in Patients with Hypertrophic Cardiomyopathy

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F15%3A10315838" target="_blank" >RIV/00216208:11130/15:10315838 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/15:10315838
Result on the web
<a href="http://dx.doi.org/10.1055/s-0034-1396900" target="_blank" >http://dx.doi.org/10.1055/s-0034-1396900</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1055/s-0034-1396900" target="_blank" >10.1055/s-0034-1396900</a>

Result language
angličtina
Original language name
How to Treat Obstructions in Patients with Hypertrophic Cardiomyopathy
Original language description
Hypertrophic cardiomyopathy (HCM) is characterized by the presence of increased thickness of the left ventricular wall that is not solely explained by abnormal loading conditions. Two-thirds of the patients with HCM have an obstruction in the left ventricle after provocation or even while at rest. This obstruction is associated with more symptoms and a worse prognosis. The two main therapeutic approaches for treating a left ventricular obstruction are alcohol septal ablation and surgical myectomy. Boththese techniques are discussed in this article. Currently, the final decision concerning the optimal invasive therapy for patients with obstructive HCM must be individualized to each patient depending on his/her wishes and expectations, way of life, age,heart morphology, and hemodynamics, as well as the experience of the treating center.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)